Shopping Cart 0
Cart Subtotal
USD 0

Global Neuromodulation Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3480

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5220

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons.

Scope of the Report:

This report studies the Neuromodulation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuromodulation market by product type and applications/end industries.

The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer's and Parkinson's diseases, and the increase in awareness regarding the safety and efficacy of neurostimulator devices. However, restrains, such as lack of trained healthcare professionals and stringent approval policies, are expected to hinder the market.

Spinal cord stimulation is the dominating segment whereas repetitive transcranial magnetic stimulation is the fastest growing segment among various neuromodulation technologies. Chronic pain management is the largest application segment and migraine is the fastest growing segment owing to the high incidence rate.

North America is the most attractive market in the global neuromodulation industry and is expected to be the first preference for new entrants due to the increasing end-use in the region. Asia-Pacific is the fastest growing market; hence the established players are focusing on the region.

The global Neuromodulation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuromodulation.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Medtronic

Boston Scientific

Jude Medical

Synapse Biomedical

Nevro

Neurosigma

Neuropace

Neuronetics

Cyber??onics

BioControl Medical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Deep Brain Stimulation

Spinal Cord Stimulation

Transcranial Magnetic Stimulation

Market Segment by Applications, can be divided into

Depression

Parkinson's

Tinnitus

Alzheimer's

Epilepsy

Ischemia

Obesity

READ MORE

Table Of Content

Scope

Table of Contents

1 Neuromodulation Market Overview

1.1 Product Overview and Scope of Neuromodulation

1.2 Classification of Neuromodulation by Types

1.2.1 Global Neuromodulation Revenue Comparison by Types (2017-2023)

1.2.2 Global Neuromodulation Revenue Market Share by Types in 2017

1.2.3 Deep Brain Stimulation

1.2.4 Spinal Cord Stimulation

1.2.5 Transcranial Magnetic Stimulation

1.3 Global Neuromodulation Market by Application

1.3.1 Global Neuromodulation Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Depression

1.3.3 Parkinson's

1.3.4 Tinnitus

1.3.5 Alzheimer's

1.3.6 Epilepsy

1.3.7 Ischemia

1.3.8 Obesity

1.4 Global Neuromodulation Market by Regions

1.4.1 Global Neuromodulation Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Neuromodulation Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuromodulation Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuromodulation Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Neuromodulation Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuromodulation Status and Prospect (2013-2023)

1.5 Global Market Size of Neuromodulation (2013-2023)

2 Manufacturers Profiles

2.1 Medtronic

2.1.1 Business Overview

2.1.2 Neuromodulation Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Medtronic Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boston Scientific

2.2.1 Business Overview

2.2.2 Neuromodulation Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Boston Scientific Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.3 Jude Medical

2.3.1 Business Overview

2.3.2 Neuromodulation Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Jude Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.4 Synapse Biomedical

2.4.1 Business Overview

2.4.2 Neuromodulation Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Synapse Biomedical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.5 Nevro

2.5.1 Business Overview

2.5.2 Neuromodulation Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Nevro Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.6 Neurosigma

2.6.1 Business Overview

2.6.2 Neuromodulation Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Neurosigma Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.7 Neuropace

2.7.1 Business Overview

2.7.2 Neuromodulation Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Neuropace Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.8 Neuronetics

2.8.1 Business Overview

2.8.2 Neuromodulation Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Neuronetics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.9 Cyber??onics

2.9.1 Business Overview

2.9.2 Neuromodulation Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Cyber??onics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.10 BioControl Medical

2.10.1 Business Overview

2.10.2 Neuromodulation Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 BioControl Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

3 Global Neuromodulation Market Competition, by Players

3.1 Global Neuromodulation Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Neuromodulation Players Market Share

3.2.2 Top 10 Neuromodulation Players Market Share

3.3 Market Competition Trend

4 Global Neuromodulation Market Size by Regions

4.1 Global Neuromodulation Revenue and Market Share by Regions

4.2 North America Neuromodulation Revenue and Growth Rate (2013-2018)

4.3 Europe Neuromodulation Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Neuromodulation Revenue and Growth Rate (2013-2018)

4.5 South America Neuromodulation Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Neuromodulation Revenue and Growth Rate (2013-2018)

5 North America Neuromodulation Revenue by Countries

5.1 North America Neuromodulation Revenue by Countries (2013-2018)

5.2 USA Neuromodulation Revenue and Growth Rate (2013-2018)

5.3 Canada Neuromodulation Revenue and Growth Rate (2013-2018)

5.4 Mexico Neuromodulation Revenue and Growth Rate (2013-2018)

6 Europe Neuromodulation Revenue by Countries

6.1 Europe Neuromodulation Revenue by Countries (2013-2018)

6.2 Germany Neuromodulation Revenue and Growth Rate (2013-2018)

6.3 UK Neuromodulation Revenue and Growth Rate (2013-2018)

6.4 France Neuromodulation Revenue and Growth Rate (2013-2018)

6.5 Russia Neuromodulation Revenue and Growth Rate (2013-2018)

6.6 Italy Neuromodulation Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Neuromodulation Revenue by Countries

7.1 Asia-Pacific Neuromodulation Revenue by Countries (2013-2018)

7.2 China Neuromodulation Revenue and Growth Rate (2013-2018)

7.3 Japan Neuromodulation Revenue and Growth Rate (2013-2018)

7.4 Korea Neuromodulation Revenue and Growth Rate (2013-2018)

7.5 India Neuromodulation Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Neuromodulation Revenue and Growth Rate (2013-2018)

8 South America Neuromodulation Revenue by Countries

8.1 South America Neuromodulation Revenue by Countries (2013-2018)

8.2 Brazil Neuromodulation Revenue and Growth Rate (2013-2018)

8.3 Argentina Neuromodulation Revenue and Growth Rate (2013-2018)

8.4 Colombia Neuromodulation Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Neuromodulation by Countries

9.1 Middle East and Africa Neuromodulation Revenue by Countries (2013-2018)

9.2 Saudi Arabia Neuromodulation Revenue and Growth Rate (2013-2018)

9.3 UAE Neuromodulation Revenue and Growth Rate (2013-2018)

9.4 Egypt Neuromodulation Revenue and Growth Rate (2013-2018)

9.5 Nigeria Neuromodulation Revenue and Growth Rate (2013-2018)

9.6 South Africa Neuromodulation Revenue and Growth Rate (2013-2018)

10 Global Neuromodulation Market Segment by Type

10.1 Global Neuromodulation Revenue and Market Share by Type (2013-2018)

10.2 Global Neuromodulation Market Forecast by Type (2018-2023)

10.3 Deep Brain Stimulation Revenue Growth Rate (2013-2023)

10.4 Spinal Cord Stimulation Revenue Growth Rate (2013-2023)

10.5 Transcranial Magnetic Stimulation Revenue Growth Rate (2013-2023)

11 Global Neuromodulation Market Segment by Application

11.1 Global Neuromodulation Revenue Market Share by Application (2013-2018)

11.2 Neuromodulation Market Forecast by Application (2018-2023)

11.3 Depression Revenue Growth (2013-2018)

11.4 Parkinson's Revenue Growth (2013-2018)

11.5 Tinnitus Revenue Growth (2013-2018)

11.6 Alzheimer's Revenue Growth (2013-2018)

11.7 Epilepsy Revenue Growth (2013-2018)

11.8 Ischemia Revenue Growth (2013-2018)

11.9 Obesity Revenue Growth (2013-2018)

12 Global Neuromodulation Market Size Forecast (2018-2023)

12.1 Global Neuromodulation Market Size Forecast (2018-2023)

12.2 Global Neuromodulation Market Forecast by Regions (2018-2023)

12.3 North America Neuromodulation Revenue Market Forecast (2018-2023)

12.4 Europe Neuromodulation Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Neuromodulation Revenue Market Forecast (2018-2023)

12.6 South America Neuromodulation Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Neuromodulation Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Neuromodulation Picture

Table Product Specifications of Neuromodulation

Table Global Neuromodulation and Revenue (Million USD) Market Split by Product Type

Figure Global Neuromodulation Revenue Market Share by Types in 2017

Figure Deep Brain Stimulation Picture

Figure Spinal Cord Stimulation Picture

Figure Transcranial Magnetic Stimulation Picture

Table Global Neuromodulation Revenue (Million USD) by Application (2013-2023)

Figure Neuromodulation Revenue Market Share by Applications in 2017

Figure Depression Picture

Figure Parkinson's Picture

Figure Tinnitus Picture

Figure Alzheimer's Picture

Figure Epilepsy Picture

Figure Ischemia Picture

Figure Obesity Picture

Table Global Market Neuromodulation Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Table Medtronic Basic Information, Manufacturing Base and Competitors

Table Medtronic Neuromodulation Type and Applications

Table Medtronic Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Boston Scientific Basic Information, Manufacturing Base and Competitors

Table Boston Scientific Neuromodulation Type and Applications

Table Boston Scientific Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Jude Medical Basic Information, Manufacturing Base and Competitors

Table Jude Medical Neuromodulation Type and Applications

Table Jude Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Synapse Biomedical Basic Information, Manufacturing Base and Competitors

Table Synapse Biomedical Neuromodulation Type and Applications

Table Synapse Biomedical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Nevro Basic Information, Manufacturing Base and Competitors

Table Nevro Neuromodulation Type and Applications

Table Nevro Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Neurosigma Basic Information, Manufacturing Base and Competitors

Table Neurosigma Neuromodulation Type and Applications

Table Neurosigma Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Neuropace Basic Information, Manufacturing Base and Competitors

Table Neuropace Neuromodulation Type and Applications

Table Neuropace Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Neuronetics Basic Information, Manufacturing Base and Competitors

Table Neuronetics Neuromodulation Type and Applications

Table Neuronetics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Cyber??onics Basic Information, Manufacturing Base and Competitors

Table Cyber??onics Neuromodulation Type and Applications

Table Cyber??onics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table BioControl Medical Basic Information, Manufacturing Base and Competitors

Table BioControl Medical Neuromodulation Type and Applications

Table BioControl Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Global Neuromodulation Revenue (Million USD) by Players (2013-2018)

Table Global Neuromodulation Revenue Share by Players (2013-2018)

Figure Global Neuromodulation Revenue Share by Players in 2016

Figure Global Neuromodulation Revenue Share by Players in 2017

Figure Global Top 5 Players Neuromodulation Revenue Market Share in 2017

Figure Global Top 10 Players Neuromodulation Revenue Market Share in 2017

Figure Global Neuromodulation Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Neuromodulation Revenue (Million USD) by Regions (2013-2018)

Table Global Neuromodulation Revenue Market Share by Regions (2013-2018)

Figure Global Neuromodulation Revenue Market Share by Regions (2013-2018)

Figure Global Neuromodulation Revenue Market Share by Regions in 2017

Figure North America Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Europe Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Neuromodulation Revenue and Growth Rate (2013-2018)

Figure South America Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Neuromodulation Revenue and Growth Rate (2013-2018)

Table North America Neuromodulation Revenue by Countries (2013-2018)

Table North America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure North America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure North America Neuromodulation Revenue Market Share by Countries in 2017

Figure USA Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Canada Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Mexico Neuromodulation Revenue and Growth Rate (2013-2018)

Table Europe Neuromodulation Revenue (Million USD) by Countries (2013-2018)

Figure Europe Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Europe Neuromodulation Revenue Market Share by Countries in 2017

Figure Germany Neuromodulation Revenue and Growth Rate (2013-2018)

Figure UK Neuromodulation Revenue and Growth Rate (2013-2018)

Figure France Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Russia Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Italy Neuromodulation Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Neuromodulation Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Neuromodulation Revenue Market Share by Countries in 2017

Figure China Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Japan Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Korea Neuromodulation Revenue and Growth Rate (2013-2018)

Figure India Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Neuromodulation Revenue and Growth Rate (2013-2018)

Table South America Neuromodulation Revenue by Countries (2013-2018)

Table South America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure South America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure South America Neuromodulation Revenue Market Share by Countries in 2017

Figure Brazil Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Argentina Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Colombia Neuromodulation Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Neuromodulation Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Neuromodulation Revenue Market Share by Countries in 2017

Figure Saudi Arabia Neuromodulation Revenue and Growth Rate (2013-2018)

Figure UAE Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Egypt Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Nigeria Neuromodulation Revenue and Growth Rate (2013-2018)

Figure South Africa Neuromodulation Revenue and Growth Rate (2013-2018)

Table Global Neuromodulation Revenue (Million USD) by Type (2013-2018)

Table Global Neuromodulation Revenue Share by Type (2013-2018)

Figure Global Neuromodulation Revenue Share by Type (2013-2018)

Figure Global Neuromodulation Revenue Share by Type in 2017

Table Global Neuromodulation Revenue Forecast by Type (2018-2023)

Figure Global Neuromodulation Market Share Forecast by Type (2018-2023)

Figure Global Deep Brain Stimulation Revenue Growth Rate (2013-2018)

Figure Global Spinal Cord Stimulation Revenue Growth Rate (2013-2018)

Figure Global Transcranial Magnetic Stimulation Revenue Growth Rate (2013-2018)

Table Global Neuromodulation Revenue by Application (2013-2018)

Table Global Neuromodulation Revenue Share by Application (2013-2018)

Figure Global Neuromodulation Revenue Share by Application (2013-2018)

Figure Global Neuromodulation Revenue Share by Application in 2017

Table Global Neuromodulation Revenue Forecast by Application (2018-2023)

Figure Global Neuromodulation Market Share Forecast by Application (2018-2023)

Figure Global Depression Revenue Growth Rate (2013-2018)

Figure Global Parkinson's Revenue Growth Rate (2013-2018)

Figure Global Tinnitus Revenue Growth Rate (2013-2018)

Figure Global Alzheimer's Revenue Growth Rate (2013-2018)

Figure Global Epilepsy Revenue Growth Rate (2013-2018)

Figure Global Ischemia Revenue Growth Rate (2013-2018)

Figure Global Obesity Revenue Growth Rate (2013-2018)

Figure Global Neuromodulation Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Neuromodulation Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Neuromodulation Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Neuromodulation Revenue Market Forecast (2018-2023)

Figure Europe Neuromodulation Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Neuromodulation Revenue Market Forecast (2018-2023)

Figure South America Neuromodulation Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Neuromodulation Revenue Market Forecast (2018-2023)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Medtronic

Boston Scientific

Jude Medical

Synapse Biomedical

Nevro

Neurosigma

Neuropace

Neuronetics

Cyber??onics

BioControl Medical

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons.

Scope of the Report:

This report studies the Neuromodulation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuromodulation market by product type and applications/end industries.

The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer's and Parkinson's diseases, and the increase in awareness regarding the safety and efficacy of neurostimulator devices. However, restrains, such as lack of trained healthcare professionals and stringent approval policies, are expected to hinder the market.

Spinal cord stimulation is the dominating segment whereas repetitive transcranial magnetic stimulation is the fastest growing segment among various neuromodulation technologies. Chronic pain management is the largest application segment and migraine is the fastest growing segment owing to the high incidence rate.

North America is the most attractive market in the global neuromodulation industry and is expected to be the first preference for new entrants due to the increasing end-use in the region. Asia-Pacific is the fastest growing market; hence the established players are focusing on the region.

The global Neuromodulation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuromodulation.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Medtronic

Boston Scientific

Jude Medical

Synapse Biomedical

Nevro

Neurosigma

Neuropace

Neuronetics

Cyber??onics

BioControl Medical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Deep Brain Stimulation

Spinal Cord Stimulation

Transcranial Magnetic Stimulation

Market Segment by Applications, can be divided into

Depression

Parkinson's

Tinnitus

Alzheimer's

Epilepsy

Ischemia

Obesity

READ MORE

Scope

Table of Contents

1 Neuromodulation Market Overview

1.1 Product Overview and Scope of Neuromodulation

1.2 Classification of Neuromodulation by Types

1.2.1 Global Neuromodulation Revenue Comparison by Types (2017-2023)

1.2.2 Global Neuromodulation Revenue Market Share by Types in 2017

1.2.3 Deep Brain Stimulation

1.2.4 Spinal Cord Stimulation

1.2.5 Transcranial Magnetic Stimulation

1.3 Global Neuromodulation Market by Application

1.3.1 Global Neuromodulation Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Depression

1.3.3 Parkinson's

1.3.4 Tinnitus

1.3.5 Alzheimer's

1.3.6 Epilepsy

1.3.7 Ischemia

1.3.8 Obesity

1.4 Global Neuromodulation Market by Regions

1.4.1 Global Neuromodulation Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Neuromodulation Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuromodulation Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuromodulation Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Neuromodulation Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuromodulation Status and Prospect (2013-2023)

1.5 Global Market Size of Neuromodulation (2013-2023)

2 Manufacturers Profiles

2.1 Medtronic

2.1.1 Business Overview

2.1.2 Neuromodulation Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Medtronic Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boston Scientific

2.2.1 Business Overview

2.2.2 Neuromodulation Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Boston Scientific Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.3 Jude Medical

2.3.1 Business Overview

2.3.2 Neuromodulation Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Jude Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.4 Synapse Biomedical

2.4.1 Business Overview

2.4.2 Neuromodulation Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Synapse Biomedical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.5 Nevro

2.5.1 Business Overview

2.5.2 Neuromodulation Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Nevro Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.6 Neurosigma

2.6.1 Business Overview

2.6.2 Neuromodulation Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Neurosigma Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.7 Neuropace

2.7.1 Business Overview

2.7.2 Neuromodulation Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Neuropace Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.8 Neuronetics

2.8.1 Business Overview

2.8.2 Neuromodulation Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Neuronetics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.9 Cyber??onics

2.9.1 Business Overview

2.9.2 Neuromodulation Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Cyber??onics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

2.10 BioControl Medical

2.10.1 Business Overview

2.10.2 Neuromodulation Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 BioControl Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

3 Global Neuromodulation Market Competition, by Players

3.1 Global Neuromodulation Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Neuromodulation Players Market Share

3.2.2 Top 10 Neuromodulation Players Market Share

3.3 Market Competition Trend

4 Global Neuromodulation Market Size by Regions

4.1 Global Neuromodulation Revenue and Market Share by Regions

4.2 North America Neuromodulation Revenue and Growth Rate (2013-2018)

4.3 Europe Neuromodulation Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Neuromodulation Revenue and Growth Rate (2013-2018)

4.5 South America Neuromodulation Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Neuromodulation Revenue and Growth Rate (2013-2018)

5 North America Neuromodulation Revenue by Countries

5.1 North America Neuromodulation Revenue by Countries (2013-2018)

5.2 USA Neuromodulation Revenue and Growth Rate (2013-2018)

5.3 Canada Neuromodulation Revenue and Growth Rate (2013-2018)

5.4 Mexico Neuromodulation Revenue and Growth Rate (2013-2018)

6 Europe Neuromodulation Revenue by Countries

6.1 Europe Neuromodulation Revenue by Countries (2013-2018)

6.2 Germany Neuromodulation Revenue and Growth Rate (2013-2018)

6.3 UK Neuromodulation Revenue and Growth Rate (2013-2018)

6.4 France Neuromodulation Revenue and Growth Rate (2013-2018)

6.5 Russia Neuromodulation Revenue and Growth Rate (2013-2018)

6.6 Italy Neuromodulation Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Neuromodulation Revenue by Countries

7.1 Asia-Pacific Neuromodulation Revenue by Countries (2013-2018)

7.2 China Neuromodulation Revenue and Growth Rate (2013-2018)

7.3 Japan Neuromodulation Revenue and Growth Rate (2013-2018)

7.4 Korea Neuromodulation Revenue and Growth Rate (2013-2018)

7.5 India Neuromodulation Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Neuromodulation Revenue and Growth Rate (2013-2018)

8 South America Neuromodulation Revenue by Countries

8.1 South America Neuromodulation Revenue by Countries (2013-2018)

8.2 Brazil Neuromodulation Revenue and Growth Rate (2013-2018)

8.3 Argentina Neuromodulation Revenue and Growth Rate (2013-2018)

8.4 Colombia Neuromodulation Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Neuromodulation by Countries

9.1 Middle East and Africa Neuromodulation Revenue by Countries (2013-2018)

9.2 Saudi Arabia Neuromodulation Revenue and Growth Rate (2013-2018)

9.3 UAE Neuromodulation Revenue and Growth Rate (2013-2018)

9.4 Egypt Neuromodulation Revenue and Growth Rate (2013-2018)

9.5 Nigeria Neuromodulation Revenue and Growth Rate (2013-2018)

9.6 South Africa Neuromodulation Revenue and Growth Rate (2013-2018)

10 Global Neuromodulation Market Segment by Type

10.1 Global Neuromodulation Revenue and Market Share by Type (2013-2018)

10.2 Global Neuromodulation Market Forecast by Type (2018-2023)

10.3 Deep Brain Stimulation Revenue Growth Rate (2013-2023)

10.4 Spinal Cord Stimulation Revenue Growth Rate (2013-2023)

10.5 Transcranial Magnetic Stimulation Revenue Growth Rate (2013-2023)

11 Global Neuromodulation Market Segment by Application

11.1 Global Neuromodulation Revenue Market Share by Application (2013-2018)

11.2 Neuromodulation Market Forecast by Application (2018-2023)

11.3 Depression Revenue Growth (2013-2018)

11.4 Parkinson's Revenue Growth (2013-2018)

11.5 Tinnitus Revenue Growth (2013-2018)

11.6 Alzheimer's Revenue Growth (2013-2018)

11.7 Epilepsy Revenue Growth (2013-2018)

11.8 Ischemia Revenue Growth (2013-2018)

11.9 Obesity Revenue Growth (2013-2018)

12 Global Neuromodulation Market Size Forecast (2018-2023)

12.1 Global Neuromodulation Market Size Forecast (2018-2023)

12.2 Global Neuromodulation Market Forecast by Regions (2018-2023)

12.3 North America Neuromodulation Revenue Market Forecast (2018-2023)

12.4 Europe Neuromodulation Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Neuromodulation Revenue Market Forecast (2018-2023)

12.6 South America Neuromodulation Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Neuromodulation Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Neuromodulation Picture

Table Product Specifications of Neuromodulation

Table Global Neuromodulation and Revenue (Million USD) Market Split by Product Type

Figure Global Neuromodulation Revenue Market Share by Types in 2017

Figure Deep Brain Stimulation Picture

Figure Spinal Cord Stimulation Picture

Figure Transcranial Magnetic Stimulation Picture

Table Global Neuromodulation Revenue (Million USD) by Application (2013-2023)

Figure Neuromodulation Revenue Market Share by Applications in 2017

Figure Depression Picture

Figure Parkinson's Picture

Figure Tinnitus Picture

Figure Alzheimer's Picture

Figure Epilepsy Picture

Figure Ischemia Picture

Figure Obesity Picture

Table Global Market Neuromodulation Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Neuromodulation Revenue (Million USD) and Growth Rate (2013-2023)

Table Medtronic Basic Information, Manufacturing Base and Competitors

Table Medtronic Neuromodulation Type and Applications

Table Medtronic Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Boston Scientific Basic Information, Manufacturing Base and Competitors

Table Boston Scientific Neuromodulation Type and Applications

Table Boston Scientific Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Jude Medical Basic Information, Manufacturing Base and Competitors

Table Jude Medical Neuromodulation Type and Applications

Table Jude Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Synapse Biomedical Basic Information, Manufacturing Base and Competitors

Table Synapse Biomedical Neuromodulation Type and Applications

Table Synapse Biomedical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Nevro Basic Information, Manufacturing Base and Competitors

Table Nevro Neuromodulation Type and Applications

Table Nevro Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Neurosigma Basic Information, Manufacturing Base and Competitors

Table Neurosigma Neuromodulation Type and Applications

Table Neurosigma Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Neuropace Basic Information, Manufacturing Base and Competitors

Table Neuropace Neuromodulation Type and Applications

Table Neuropace Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Neuronetics Basic Information, Manufacturing Base and Competitors

Table Neuronetics Neuromodulation Type and Applications

Table Neuronetics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Cyber??onics Basic Information, Manufacturing Base and Competitors

Table Cyber??onics Neuromodulation Type and Applications

Table Cyber??onics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table BioControl Medical Basic Information, Manufacturing Base and Competitors

Table BioControl Medical Neuromodulation Type and Applications

Table BioControl Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)

Table Global Neuromodulation Revenue (Million USD) by Players (2013-2018)

Table Global Neuromodulation Revenue Share by Players (2013-2018)

Figure Global Neuromodulation Revenue Share by Players in 2016

Figure Global Neuromodulation Revenue Share by Players in 2017

Figure Global Top 5 Players Neuromodulation Revenue Market Share in 2017

Figure Global Top 10 Players Neuromodulation Revenue Market Share in 2017

Figure Global Neuromodulation Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Neuromodulation Revenue (Million USD) by Regions (2013-2018)

Table Global Neuromodulation Revenue Market Share by Regions (2013-2018)

Figure Global Neuromodulation Revenue Market Share by Regions (2013-2018)

Figure Global Neuromodulation Revenue Market Share by Regions in 2017

Figure North America Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Europe Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Neuromodulation Revenue and Growth Rate (2013-2018)

Figure South America Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Neuromodulation Revenue and Growth Rate (2013-2018)

Table North America Neuromodulation Revenue by Countries (2013-2018)

Table North America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure North America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure North America Neuromodulation Revenue Market Share by Countries in 2017

Figure USA Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Canada Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Mexico Neuromodulation Revenue and Growth Rate (2013-2018)

Table Europe Neuromodulation Revenue (Million USD) by Countries (2013-2018)

Figure Europe Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Europe Neuromodulation Revenue Market Share by Countries in 2017

Figure Germany Neuromodulation Revenue and Growth Rate (2013-2018)

Figure UK Neuromodulation Revenue and Growth Rate (2013-2018)

Figure France Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Russia Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Italy Neuromodulation Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Neuromodulation Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Neuromodulation Revenue Market Share by Countries in 2017

Figure China Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Japan Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Korea Neuromodulation Revenue and Growth Rate (2013-2018)

Figure India Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Neuromodulation Revenue and Growth Rate (2013-2018)

Table South America Neuromodulation Revenue by Countries (2013-2018)

Table South America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure South America Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure South America Neuromodulation Revenue Market Share by Countries in 2017

Figure Brazil Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Argentina Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Colombia Neuromodulation Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Neuromodulation Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Neuromodulation Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Neuromodulation Revenue Market Share by Countries in 2017

Figure Saudi Arabia Neuromodulation Revenue and Growth Rate (2013-2018)

Figure UAE Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Egypt Neuromodulation Revenue and Growth Rate (2013-2018)

Figure Nigeria Neuromodulation Revenue and Growth Rate (2013-2018)

Figure South Africa Neuromodulation Revenue and Growth Rate (2013-2018)

Table Global Neuromodulation Revenue (Million USD) by Type (2013-2018)

Table Global Neuromodulation Revenue Share by Type (2013-2018)

Figure Global Neuromodulation Revenue Share by Type (2013-2018)

Figure Global Neuromodulation Revenue Share by Type in 2017

Table Global Neuromodulation Revenue Forecast by Type (2018-2023)

Figure Global Neuromodulation Market Share Forecast by Type (2018-2023)

Figure Global Deep Brain Stimulation Revenue Growth Rate (2013-2018)

Figure Global Spinal Cord Stimulation Revenue Growth Rate (2013-2018)

Figure Global Transcranial Magnetic Stimulation Revenue Growth Rate (2013-2018)

Table Global Neuromodulation Revenue by Application (2013-2018)

Table Global Neuromodulation Revenue Share by Application (2013-2018)

Figure Global Neuromodulation Revenue Share by Application (2013-2018)

Figure Global Neuromodulation Revenue Share by Application in 2017

Table Global Neuromodulation Revenue Forecast by Application (2018-2023)

Figure Global Neuromodulation Market Share Forecast by Application (2018-2023)

Figure Global Depression Revenue Growth Rate (2013-2018)

Figure Global Parkinson's Revenue Growth Rate (2013-2018)

Figure Global Tinnitus Revenue Growth Rate (2013-2018)

Figure Global Alzheimer's Revenue Growth Rate (2013-2018)

Figure Global Epilepsy Revenue Growth Rate (2013-2018)

Figure Global Ischemia Revenue Growth Rate (2013-2018)

Figure Global Obesity Revenue Growth Rate (2013-2018)

Figure Global Neuromodulation Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Neuromodulation Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Neuromodulation Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Neuromodulation Revenue Market Forecast (2018-2023)

Figure Europe Neuromodulation Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Neuromodulation Revenue Market Forecast (2018-2023)

Figure South America Neuromodulation Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Neuromodulation Revenue Market Forecast (2018-2023)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Medtronic

Boston Scientific

Jude Medical

Synapse Biomedical

Nevro

Neurosigma

Neuropace

Neuronetics

Cyber??onics

BioControl Medical